TP53 and cancer: In this patient cohort, complete response to radiotherapy was associated with positive p53 immunostaining (P<0.04, χ2-test; Supplementary Figure 4C) and as a consequence, positive p53 immunostaining was a significant predictor of cancer-free survival (P=0.01, log rank test; Supplementary Figure 5A).